Skip to main content

Quantification of Erectile Dysfunction After Prostate Cancer Treatment

  • Chapter
  • First Online:

Part of the book series: Contemporary Endocrinology ((COE))

Abstract

Determining if a man has erectile dysfunction (ED) seems like an innocuous task. However, this seemingly straightforward determination is fraught with peril, especially when applied to the reporting of erectile function after prostate cancer treatment. Is the wide range in ED outcomes following prostate cancer treatment really due to inherent biologic variability, or are there biases or other factors at work confounding the data? The goal of this chapter is to detail the specific difficulties for the quantification of ED in the context of challenges inherent to all scientific research: optimization of a study’s internal and external validity. Only through the understanding of the factors that influence the quantification of ED can consistent, standardized outcomes be obtained to advance the field of study.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Burnett, A. L., Aus, G., Canby-Hagino, E. D., Cookson, M. S., D’Amico, A. V., Dmochowski, R. R., et al. (2007). Erectile function outcome reporting after clinically localized prostate cancer treatment. Journal d’Urologie, 178, 597–601.

    Google Scholar 

  2. Meyer, J. P., Gillatt, D. A., Lockyer, R., & Macdonagh, R. (2003). The effect of erectile dysfunction on the quality of life of men after radical prostatectomy. BJU International, 92, 929–931.

    Article  PubMed  Google Scholar 

  3. Motulsky, H. (1995). Intuitive biostatistics. Oxford University Press: New York, NY.

    Google Scholar 

  4. Hirsch, M., Donatucci, C., Glina, S., Montague, D., Montorsi, F., & Wyllie, M. (2004). Standards for clinical trials in male sexual dysfunction: Erectile dysfunction and rapid ejaculation. In T. F. Lue, R. Basson, R. Rosen, F. Giuliano, S. Khoury & F. Montorsi (Eds.) Sexual medicine: Sexual dysfunctions in men and women (pp. 223–240). Paris: Health Publications, chapter 8.

    Google Scholar 

  5. Hulley, S. B., Cummings, S. R., Browner, W. S., Grady, D. G., & Newman, T. B. (2007). Designing clinical research (3rd ed.). Lippincott Williams & Wilkins: Philadelphia, PA.

    Google Scholar 

  6. Krupski, T. L., Saigal, C. S., & Litwin, M. S. (2003). Variation in continence and potency by definition. Journal d’Urologie, 170, 1291–1294.

    Google Scholar 

  7. (1993). NIH Consensus Development Panel on Impotence. NIH Consensus Conference. Impotence. The Journal of the American Medical Association, 270, 83–90.

    Google Scholar 

  8. Jardin, A., Wagner, G., Khoury, S., Giuliano, F., Padma-Nathan, H., & Rosen, R. (1999). Recommendations of the 1st International Consultation on Erectile Dysfunction. Cosponsored by the World Health Organization, International Consultation on Urological Diseases, and Société Internationale d’Urologie. Paris, France: July 1–3, 1999 (pp. 709–726). Geneva, Switzerland: World Health Organization.

    Google Scholar 

  9. Salonia, A., Zanni, G., Gallina, A., Sacca, A., Sangalli, M., Naspro, R., et al. (2006). Baseline potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy. European Urology, 50, 360–365.

    Article  PubMed  Google Scholar 

  10. Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997). The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology, 49, 822–830.

    Article  CAS  PubMed  Google Scholar 

  11. Ramanthan, R., Mulhall, J., Rao, S., Leung, R., Martinez Salamanca, J. I., Mandhani, A., et al. (2007). Predictive correlation between the International Index of Erectile Function (IIEF) and Sexual Health Inventory for Men (SHIM): Implications for calculating a derived SHIM for clinical use. The Journal of Sexual Medicine, 4, 1336–1344.

    Article  Google Scholar 

  12. Alberson, M., Joniau, S., & van Poppel, H. (2007). The use of the IIEF-5 questionnaire for evaluation of erectile dysfunction following nerve-sparing radical prostatectomy. The Journal of Sexual Medicine, 4(Supplement 2), 105–107.

    Google Scholar 

  13. Cappelleri, J. C., & Rosen, R. C. (2005). The Sexual Health Inventory for Men (SHIM): A 5-year review of research and clinical experience. International Journal of Impotence Research, 17, 307–319 [Review].

    Article  CAS  PubMed  Google Scholar 

  14. Donatucci, C. F., & Greenfield, J. M. (2006). Recovery of sexual function after prostate cancer treatment. Current Opinion in Urology, 16, 444–448.

    Article  PubMed  Google Scholar 

  15. Goldstraw, M., Anderson, C. J., Patil, K., Dasgupta, P., & Kirby, R. (2006). Does robotically assisted Radical Prostatectomy result in better preservation of erectile function. BJU International, 98, 721–722.

    Article  PubMed  Google Scholar 

  16. Henderson, A., Andreyev, H. J., Stephens, R., & Dearnaley, D. (2006). Patient and physician reporting of symptoms and health-related quality of life in trials of treatment for early prostate cancer: Considerations for future studies. Clinical Oncology, 18, 735–743.

    Article  CAS  PubMed  Google Scholar 

  17. Incrocci, L. (2006). Sexual function after external-beam radiotherapy for prostate cancer: What do we know? Critical Reviews in Oncology/Hematology, 57, 165–173.

    Article  PubMed  Google Scholar 

  18. Montague, D. K., Jarow, J. P., Broderick, G. A., Dmochowski, R. R., Heaton, J. P., Lue, T. F., et al. (2005). Erectile dysfunction guideline update panel. Journal d’Urologie, 174, 230–239.

    Google Scholar 

  19. Nag, S., Ellis, R. J., Merrick, G. S., Bahnson, R., Wallner, K., Stock, R., et al. (2002). American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy. International Journal of Radiation Oncology, Biology, Physics, 54, 462–470.

    Article  PubMed  Google Scholar 

  20. Merrick, G. S., Butler, W. M., Galbreath, R. W., Stipetich, R. L., Abel, L. J., & Lief, J. H. (2002). Erectile function after permanent prostate brachytherapy. International Journal of Radiation Oncology, Biology, Physics, 52, 893–902.

    Article  PubMed  Google Scholar 

  21. Quinlan, D. M., Epstein, J. I., Carter, B. S., & Walsh, P. C. (1991). Sexual function following radical prostatectomy: Influence of preservation of neurovascular bundles. Journal d’Urologie, 145, 998–1002.

    CAS  Google Scholar 

  22. Noldus, J., Hammerer, P., Graefen, M., & Huland, H. (1997). Surgical therapy for localized prostatic carcinoma. Journal of Cancer Research and Clinical Oncology, 123, 180–184.

    CAS  PubMed  Google Scholar 

  23. Catalona, W. J., Carvalhal, G. F., Mager, D. E., & Smith, D. S. (1999). Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. Journal d’Urologie, 162, 433–438.

    CAS  Google Scholar 

  24. Stanford, J. L., Feng, Z., Hamilton, A. S., Gilliland, F. D., Stephenson, R. A., Eley, J. W., et al. (2000). Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. Journal of the American Medical Association, 283, 354–360.

    Article  CAS  PubMed  Google Scholar 

  25. Breza, J., Aboseif, S. R., Orvis, B. R., Lue, T. F., & Tanagho, E. A. (1989). Detailed anatomy of penile neurovascular structures: Surgical significance. Journal d’Urologie, 141, 437–443.

    CAS  Google Scholar 

  26. Shipley, W. U., Zietman, A. L., Hanks, G. E., Coen, J. J., Caplan, R. J., Won, M., et al. (1994). Treatment related sequelae following external beam radiation for prostate cancer: A review with an update in patients with stages T1 and T2 tumor. Journal d’Urologie, 152, 1799–1805.

    CAS  Google Scholar 

  27. Perez, C. A., Michalski, J., & Lockett, M. A. (1995). Radiation therapy in the treatment of localized prostate cancer: An alternative to an emerging consensus. Missouri Medicine, 92, 696–704.

    CAS  PubMed  Google Scholar 

  28. Wilder, R. B., Chou, R. H., Ryu, J. K., Stern, R. L., Wong, M. S., Ji, M., et al. (2000). Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: Preliminary results. American Journal of Clinical Oncology, 23, 330–333.

    Article  CAS  PubMed  Google Scholar 

  29. Salomon, L., Anastasiadis, A. G., Katz, R., De La Taille, A., Saint, F., Vordos, D., et al. (2002). Urinary continence and erectile function: A prospective evaluation of functional results after radical laparoscopic prostatectomy. European Urology, 42, 338–343.

    Article  PubMed  Google Scholar 

  30. Zelefsky, M. J., Hollister, T., Raben, A., Matthews, S., & Wallner, K. E. (2000). Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics, 47, 1261–1266.

    Article  CAS  PubMed  Google Scholar 

  31. Hoffman, R. M., Hunt, W. C., Gilliland, F. D., Stephenson, R. A., & Potosky, A. L. (2003). Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the prostate cancer outcomes study. Cancer, 97, 1653–1662.

    Article  PubMed  Google Scholar 

  32. Helgason, A. R., Adolfsson, J., Dickman, P., Arver, S., Fredrickson, M., & Steineck, G. (1997). Factors associated with waning sexual function among elderly men and prostate cancer patients. Journal d’Urologie, 158, 155–159.

    CAS  Google Scholar 

  33. Talcott, J. A., Clark, J. A., Stark, P. C., & Mitchell, S. P. (2001). Long-term treatment related complications of brachytherapy for early prostate cancer: A survey of patients previously treated. Journal d’Urologie, 166, 494–499.

    CAS  Google Scholar 

  34. Ellis, D. S., Mann, T. B., & Rewcastle, J. C. (2007). Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Urology, 69, 306–310.

    Article  PubMed  Google Scholar 

  35. Litwin, M. S., Lubeck, D. P., Henning, J. M., & Carroll, P. R. (1998). Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the CaPSURE database. Journal d’Urologie, 159, 1988–1992.

    CAS  Google Scholar 

  36. Phillips, C. V., & Goodman, K. J. (2004). The missed lessons of Sir Austin Bradford Hill. Epidemiologic Perspectives & Innovations, 1, 3.

    Article  Google Scholar 

  37. Hill, A. B. (1965). The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine, 58, 295–300.

    CAS  PubMed  Google Scholar 

  38. Miller, D. C., Wei, J. T., Dunn, R., Montie, J., Pimentel, H., Sandler, H. M., et al. (2006). Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: Potential influence of sexual motivation and/or indifference. Urology, 68, 166–171.

    Article  PubMed  Google Scholar 

  39. Stephenson, R. A., Mori, M., Hsieh, Y. C., Beer, T. M., Stanford, J. T., Gilliland, F. D., et al. (2005). Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: Patient reported use and outcomes from the surveillance, epidemiology, and end results prostate cancer outcomes study. Journal d’Urologie, 174, 646–650.

    Google Scholar 

  40. Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994). Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. Journal d’Urologie, 151(1), 54–61.

    CAS  Google Scholar 

  41. Rabbani, F., Stapleton, A. M., Kattan, M. W., Wheeler, T. M., & Scardino, P. T. (2000). Factors predicting recovery of erections after radical prostatectomy. Journal d’Urologie, 164, 1929–1934.

    CAS  Google Scholar 

  42. Merrick, G. S., Butler, W. M., Wallner, K. E., Galbreath, R. W., Anderson, R. L., Kurko, B. S., et al. (2005). Erectile function after prostate brachytherapy. International Journal of Radiation Oncology, Biology, Physics, 62, 437–447.

    Article  PubMed  Google Scholar 

  43. Shelley, M., Wilt, T., Coles, B., & Mason, M. (2007). Cryotherapy for localized prostate cancer. Cochrane Database of Systematic Reviews 2007, Issue 3. Art No.:CD005010. DOI: 10.1002/14651858.CD005010.pub2.

    Google Scholar 

  44. Hubosky, S. G., Fabrizio, M. D., Schellhammer, P. F., Barone, B. B., Tepera, C. M., & Given, R. W. (2007). Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: Critical evaluation of short-term outcomes, complications, and patient quality of life. Journal of Endourology, 21, 1521–1531.

    Article  PubMed  Google Scholar 

  45. Mulcahy, J. J. (2000). Erectile function after radical prostatectomy. Seminars in Urologic Oncology, 18, 71–75.

    CAS  PubMed  Google Scholar 

  46. Mulhall, J. P. (2008). Penile rehabilitation following radical prostatectomy. Current Opinion in Urology, 18(6), 613–620.

    Google Scholar 

  47. Schover, L. R., Fouladi, R. T., Warneke, C. L., Neese, L., Klein, E. A., Zippe, C., et al. (2002). Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer, 95, 1773–1785.

    Article  PubMed  Google Scholar 

  48. Bianco, F., Kattan, M., Eastham, J., Scardino, P., & Mulhall, J. P. (2001). The surgeon and surgical volume as predictors of erectile function and outcomes following prostatectomy. The Journal of Sexual Medicine, 1(suppl 1), 33. Abstract 015.

    Google Scholar 

  49. Quinlan, D. M., Epstein, J. I., Carter, B. S., & Walsh, P. C. (1991). Sexual function following radical prostatectomy: Influence of preservation of neurovascular bundles. Journal d’Urologie, 145, 998–1002.

    CAS  Google Scholar 

  50. Dubbelman, Y. D., Dohle, G. R., & Schröder, F. H. (2006). Sexual function before and after radical retropubic prostatectomy: A systematic review of prognostic indicators for a successful outcome. European Urology, 50, 711–720.

    Article  PubMed  Google Scholar 

  51. Catalona, W. J., & Basler, J. W. (1993). Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. Journal d’Urologie, 150, 905–907.

    CAS  Google Scholar 

  52. Jonler, M., Messing, E. M., Rhodes, P. R., & Bruskewitz, R. C. (1994). Sequelae of radical prostatectomy. British Journal of Urology, 74, 352–358.

    Article  CAS  PubMed  Google Scholar 

  53. Vegh, A. (1997). Two methods in the treatment of prostate cancer T1-T2. Acta Chirurgica Hungarica, 36, 383–385.

    CAS  PubMed  Google Scholar 

  54. Noldus, J., Michl, U., Graefen, M., Haese, A., Hammerer, P., & Huland, H. (2002). Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy. European Urology, 42, 118–124.

    Article  PubMed  Google Scholar 

  55. Salomon, L., Saint, F., Anastasiadis, A. G., Sebe, P., Chopin, D., & Abbou, C. C. (2003). Combined reporting of cancer control and functional results of radical prostatectomy. European Urology, 44, 656–660.

    Article  PubMed  Google Scholar 

  56. Penson, D. F., McLerran, D., Fend, Z., Li, L., Albretsen, P. C., Gilliland, F. D., et al. (2008). 5-Year urinary and sexual outcomes after radical prostatectomy: Results from the prostate cancer outcomes study. Journal d’Urologie, 179, S40–S44.

    Google Scholar 

  57. Guillonneau, B., & Vallancien, G. (2000). Laparoscopic radical prostatectomy: The Montsouris experience. Journal d’Urologie, 163, 418–422.

    CAS  Google Scholar 

  58. Katz, R., Salomon, L., Hoznek, A., de la Taille, A., Vordos, D., Cicco, A., et al. (2002). Patient reported sexual function following laparoscopic radical prostatectomy. Journal d’Urologie, 168, 2078–2082.

    Google Scholar 

  59. Hart, K. B., Duclos, M., Shamsa, F., & Forman, J. D. (1996). Potency following conformal neutron/photon irradiation for localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics, 35, 881–884.

    Article  CAS  PubMed  Google Scholar 

  60. Reddy, S. M., Ruby, J., Wallace, M., & Forman, J. D. (1997). Patient self-assessment of complications and quality of life after conformal neutron and photon irradiation for localized prostate cancer. Radiation Oncology Investigations, 5, 252–256.

    Article  CAS  PubMed  Google Scholar 

  61. Hanks, G. E., Hanlon, A. L., Pinover, W. H., al-Saleem, T. I., & Schultheiss, T. E. (1997). Radiation therapy as treatment for stage T1c prostate cancers. World Journal of Urology, 15, 369–372.

    Article  CAS  PubMed  Google Scholar 

  62. Wilder, R. B., Chou, R. H., Ryu, J. K., Stern, R. L., Wong, M. S., Ji, M., et al. (2000). Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: Preliminary results. American Journal of Clinical Oncology, 23, 330–333.

    Article  CAS  PubMed  Google Scholar 

  63. Yeoh, E. E., Fraser, R. J., McGowan, R. E., Botten, R. J., Di Matteo, A. C., Roos, D. E., et al. (2003). Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: Early results of a phase III randomized trial. International Journal of Radiation Oncology, Biology, Physics, 55, 943–955.

    Article  PubMed  Google Scholar 

  64. Michalski, J. M., Winter, K., Purdy, J. A., Wilder, R. B., Perez, C. A., Roach, M., et al. (2003). Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II. International Journal of Radiation Oncology, Biology, Physics, 56, 192–198.

    Article  PubMed  Google Scholar 

  65. Wallner, K., Roy, J., Zelefsky, M., Fuks, Z., & Harrison, L. (1994). Short-term freedom from disease progression after I-125 prostate implantation. International Journal of Radiation Oncology, Biology, Physics, 30, 405–409.

    CAS  PubMed  Google Scholar 

  66. Wallner, K., Roy, J., & Harrison, L. (1996). Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. Journal of Clinical Oncology, 14, 449–453.

    CAS  PubMed  Google Scholar 

  67. Potosky, A., Knopf, K., Clegg, L., Albertsen, P., Stanford, J., & Hamilton, A. (2001). Quality-of-life outcomes after primary androgen deprivation therapy: Results from the prostate cancer outcomes study. Journal of Clinical Oncology, 19, 3750–3757.

    CAS  PubMed  Google Scholar 

  68. Potosky, A., Reeve, B., Clegg, L., Hoffman, R., Stephenson, R., Albretsen, P., et al. (2002). Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. Journal of the National Cancer Institute, 94, 430–437.

    PubMed  Google Scholar 

  69. Bahn, D. K., Lee, F., Badalament, R., Kumar, A., Greski, J., & Chernick, M. (2002). Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology, 60(suppl 2A), 3–11.

    Article  PubMed  Google Scholar 

  70. Han, K., Cohen, J. K., Miller, R. J., Pantuck, A. J., Freitas, D. G., Cuevas, C. A., et al. (2003). Treatment of organ confined prostate cancer with third generation cryosurgery: Preliminary multicenter experience. Journal d’Urologie, 170, 1126–1130.

    Google Scholar 

  71. Asterling, S., & Greene, D. R. (2009). Prospective evaluation of sexual function in patients receiving cryosurgery as a primary radical treatment for localized prostate cancer. BJU International, 103, 788–792.

    Article  PubMed  Google Scholar 

  72. Jones, J. S., Rewcastle, J. C., Donnelly, B. J., Lugnani, F. M., Pisters, L. L., & Katz, A. E. (2008). Whole gland primary prostate cryoablation: Initial results from the cryo on-line data registry. Journal d’Urologie, 180, 554–558.

    Google Scholar 

  73. Siegel, T., Moul, J. W., Spevak, M., Alvord, W. G., & Costabile, R. A. (2001). The development of erectile dysfunction in men treated for prostate cancer. Journal d’Urologie, 165, 430–435.

    CAS  Google Scholar 

  74. Sharkey, J., Cantor, A., Solc, Z., Huff, W., Chovnick, S. D., Behar, R. J., et al. (2002). Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer. Current Urology Reports, 3, 250–257.

    PubMed  Google Scholar 

  75. Schwartz, K., Bunner, S., Bearer, R., & Severson, R. K. (2002). Complications from treatment for prostate carcinoma among men in the Detroit area. Cancer, 95, 82–89.

    Article  PubMed  Google Scholar 

  76. Cappelleri, J. C., Siegel, R. L., Glasser, D. B., Osterloh, I. H., & Rosen, R. C. (2001). Relationship between patient self-assessment of erectile dysfunction and the sexual health inventory for men. Clinical Therapeutics, 23, 1707–1719.

    Article  CAS  PubMed  Google Scholar 

  77. Rosen, R. C., Cappelleri, J. C., Smith, M. D., Lipsky, J., & Peña, B. M. (1999). Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. International Journal of Impotence Research, 11, 319–326.

    Article  CAS  PubMed  Google Scholar 

  78. Borghede, G., Karlsson, J., & Sullivan, M. (1997). Quality of life in patients with prostatic cancer: Results from a Swedish population study. Journal d’Urologie, 158, 1477–1485. Discussion 1486.

    CAS  Google Scholar 

  79. Donovan, J. L., Abrams, P., Peters, T. J., Kay, H. E., Reynard, J., Chapple, C., et al. (1996). The ICS-‘BPH’ Study: The psychometric validity and reliability of the ICS male questionnaire. British Journal of Urology, 77, 554–562.

    CAS  PubMed  Google Scholar 

  80. Frankel, S. J., Donovan, J. L., Peters, T. I., Abrams, P., Dabhoiwala, N. F., Osawa, D., et al. (1998). Sexual dysfunction in men with lower urinary tract symptoms. Journal of Clinical Epidemiology, 51, 677–685.

    Article  CAS  PubMed  Google Scholar 

  81. O’Leary, M. P., Fowler, F. J., Lenderking, W. R., Barber, B., Sagnier, P. P., Guess, H. A., et al. (1995). A brief male sexual function inventory for urology. Urology, 46, 697–706.

    Article  PubMed  Google Scholar 

  82. Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., & Brook, R. H. (1998). The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Medical Care, 36, 1002–1012.

    Article  CAS  PubMed  Google Scholar 

  83. Wei, J. T., Dunn, R. L., Litwin, M. S., Sandler, H. M., & Sanda, M. G. (2000). Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology, 56, 899–905.

    Article  CAS  PubMed  Google Scholar 

  84. Trotti, A., Byhardt, R., Stetz, J., Gwede, C., Corn, B., Fu, K., et al. (2000). Common toxicity criteria: Version 2.0. an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 47, 13–47. Review.

    Article  CAS  PubMed  Google Scholar 

  85. Kedia, S., Zippe, C. D., Agarwal, A., Nelson, D. R., & Lakin, M. M. (1999). Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer. Urology, 54, 308–312.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tobias S. Köhler .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Albaugh, J., Wayment, R.O., Köhler, T.S. (2011). Quantification of Erectile Dysfunction After Prostate Cancer Treatment. In: McVary, K. (eds) Contemporary Treatment of Erectile Dysfunction. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-60327-536-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-536-1_10

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-535-4

  • Online ISBN: 978-1-60327-536-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics